Co-Authors
This is a "connection" page, showing publications co-authored by ANDREW DINARDO and Tomoki Nishiguchi.
Connection Strength
1.579
-
Bacillus Calmette-Gu?rin vaccination as defense against SARS-CoV-2 (BADAS): a randomized controlled trial to protect healthcare workers in the USA by enhanced trained immune responses. Trials. 2023 Oct 04; 24(1):636.
Score: 0.237
-
Gene expression signatures identify biologically and clinically distinct tuberculosis endotypes. Eur Respir J. 2022 09; 60(3).
Score: 0.221
-
Increased DNA methylation, cellular senescence and premature epigenetic aging in guinea pigs and humans with tuberculosis. Aging (Albany NY). 2022 03 07; 14(5):2174-2193.
Score: 0.213
-
Reversing Post-Infectious Epigenetic-Mediated Immune Suppression. Front Immunol. 2021; 12:688132.
Score: 0.202
-
Tuberculosis endotypes to guide stratified host-directed therapy. Med. 2021 03 12; 2(3):217-232.
Score: 0.197
-
DNA hypermethylation during tuberculosis dampens host immune responsiveness. J Clin Invest. 2020 06 01; 130(6):3113-3123.
Score: 0.188
-
Schistosomiasis Induces Persistent DNA Methylation and Tuberculosis-Specific Immune Changes. J Immunol. 2018 07 01; 201(1):124-133.
Score: 0.163
-
Persistent tailoring of MSC activation through genetic priming. bioRxiv. 2024 Feb 07.
Score: 0.061
-
Disseminated cryptococcosis and anti-granulocyte-macrophage colony-stimulating factor autoantibodies: An underappreciated association. Mycoses. 2021 Jun; 64(6):576-582.
Score: 0.049
-
Perspective for Precision Medicine for Tuberculosis. Front Immunol. 2020; 11:566608.
Score: 0.048